< Terug naar vorige pagina
Octrooi
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine are disclosed for use in the treatment of cancer, especially in the treatment of cancer where the patient shows resistance, for example, in a patient with cells with a lowered level of nucleoside transporter proteins and/or with nucleoside kinase-deficient cells and/or with mycoplasma-infected cells and/or with cells with a raised level of thymidylate synthase.
Octrooi-publicatienummer: US9655915
Jaar aanvraag: 2015
Jaar toekenning: 2017
Jaar van publicatie: 2017
Status: Toegewezen
URI: link to Espacenet
Technologiedomeinen: Farmaceutische producten
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie KULeuven